If your child has severe eczema, learn how he or she could participate in this research study of an oral study drug for children 6 months to 11 years of age.
The purpose of this study is to examine how the body processes the study drug, evaluate drug safety and assess how the safety and taste hold up (tolerability and palatability) in children (6 months to 11 years old) with severe atopic dermatitis, also known as eczema. The study medication comes in a tablet form or a solution that will be taken by mouth.
WHO MAY PARTICIPATE IN THIS STUDY?
Your child may qualify for this research study, if the following applies to your child:
- Your child is between 6 months to 11 years old
- Your child has severe Atopic Dermatitis
- Your child is experiencing active Atopic Dermatitis symptoms, such as: itchiness, irritated dry skin, redness, etc.
You may receive reimbursement for your time and travel expenses related to study participation.
Please visit http://www.clinicaltrialsandme.com/M16-049 for locations participating in the study.